Phase I trial of liposomal doxorubicin and ZD 1839 in patients with refractory gynecological malignancies or metastatic breast cancer
Year: 2006
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: Massachusetts General Hospital, Dana-Farber Cancer Institute
Language: English
Subfield: Reproductive Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2227199615
